Respondents to APA Poll Express Confidence in Psychiatry as Innovative Field

Nearly three-quarters of respondents to anAPA survey released this week said that they believe psychiatry is an innovative field that helps people with mental and substance use disorders. In addition, half of the respondents said they would consider brain imaging or genetic testing if it was recommended by a physician.The survey asked respondents a series of questions about their awareness of a variety of innovative mental health tests and treatments —brain imaging, genetic testing, ketamine, psychedelic drugs, and deep brain stimulation—as well as about emerging technologies such as artificial intelligence (AI), chatbots, and virtual reality. Respondents were also queried about current events, stress, and anxiety.Overall awareness of some of the latest tests and treatments for mental or substance use disorders is generally low: 40% of respondents said they had seen, read, or heard “some” or “a lot” about brain imaging (the remainder said they had seen, read, or heard not much or nothing at all). Thirty-nine percent said they knew about genetic testing, and the same percentage said they had seen, read, or heard about psychedelic drugs as they relate to treatment.A total of 33% said they knew about ketamine as a treatment for depression, and smaller percentages said they knew about deep brain stimulation, transcranial magnetic stimulation, or biomarkers to predict medication effectiveness or the development of mental health conditions.However, 72% said they agreed ...
Source: Psychiatr News - Category: Psychiatry Tags: and deep brain stimulation APA survey artificial intelligence brain imaging climate change genetic testing gun violence. ketamine psychedelic drugs psychiatric innovation Source Type: research